|Number of Constituents||926|
|Index Inception Date||December 31, 2015|
|Base Index Value||100|
|Total Return Index Value (as of 12/31/2017)||1308.13|
The Syntax Stratified Europe and Asia Developed Markets Index™ is the stratified-weight version of the MSCI EAFE Index. It holds the same constituents as the MSCI EAFE Index but the weight of each company is based on Syntax’s patented methodology to control exposure to related business risks (RBRs).
|MSCI EAFE Eq. Weight||-0.7||-0.7||17.7||8.7||8.9||6.9||4.8||13.2|
|MSCI EAFE Eq. Weight||27.8||4.1||3.1||-2.6||23.1||16.9||-14.6||14.6||38.5||-42.6|
|Div. Yld.||P / E Ratio||P / B Ratio|
|MSCI EAFE Eq. Weight||2.25||14.3||1.59|
|Medipal Holdings Corporation||0.56|
|Suzuken Co. Ltd.||0.54|
|Alfresa Holdings Corporation||0.50|
|Hisamitsu Pharmaceutical Co. Inc.||0.45|
|Taisho Pharmaceutical Holdings Co. Ltd.||0.43|
Past performance is no guarantee of future results. The inception date of the Syntax Europe and Asia Developed Markets Index is 01/01/2016. Charts and graphs are provided for illustrative purposes only.
The Syntax Europe and Asia Developed Markets is the property of Locus Analytics, LLC, which has contracted with NYSE to calculate and maintain the Indices. The Indices are not sponsored by NYSE or its affiliates or its third party licensors. The MSCI EAFE Index was used by Locus Analytics, LLC as the reference universe for selection of the companies included in the Syntax Stratified Europe and Asia Developed Markets Index (“SEADM Index”). MSCI does not in any way sponsor, support, promote or endorse the SEADM Index. MSCI was not and is not involved in any way in the creation, calculation, maintenance or review of the Index. The MSCI EAFE Index was provided on an “as is” basis. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating the MSCI EAFE Index (collectively, the “MSCI Parties”) expressly disclaim all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non‑infringement, merchantability and fitness for a particular purpose). Without limiting any of the foregoing, in no event shall any of the MSCI Parties have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages in connection with the MSCI EAFE Index or the SEADM Index. Syntax®, Stratified®, Stratified Indices®, Stratified-Weight™, and Locus® are trademarks or registered trademarks of Locus Analytics, LLC.
Index performance does not represent actual fund or portfolio performance and such performance does not reflect the actual investment experience of any investor. An investor cannot invest directly in an index. In addition, the results actual investors might have achieved would have differed from those shown because of differences in the timing, amounts of their investments, and fees and expenses associated with an investment in a portfolio invested in accordance with an index. None of the Syntax Indices or the benchmark indices portrayed herein charge management fees or incur brokerage expenses, and no such fees or expenses were deducted from the performance shown; provided, however, that the returns of any investment portfolio invested in accordance with such indices would be net of such fees and expenses. Additionally, none of these indices lend securities, and no revenues from securities lending were added to the performance shown. Performance shown is unaudited and subject to revision. This site may include materials and documents containing forward-looking statements which are based on our expectations and projections as of the date made. Past returns are not necessarily predictive of future returns.
Benchmark data for the MSCI EAFE and MSCI EAFE Equal Weight are provided by MSCI.
Beta is a measure of relative risk, calculated as the covariance of the Index with a benchmark divided by the variance of the benchmark. Volatility is the annualized standard deviation of index returns. Sharpe ratio is a risk- adjusted measure calculated using standard deviation and excess return to determine reward per unit of risk. A higher Sharpe ratio indicates better risk-adjusted performance. Beta, volatility, and Sharpe ratio are calculated using monthly returns from 01/04/2008 to 3/31/18. Weighted Average Stock Price-to-Earnings Ratio (P/E Ratio) is the harmonic weighted average of the ratio of each stock’s share price to its trailing 12 month earnings per share. Weighted Average Stock Price-to-Book-Value Ratio (P/B Ratio) is the harmonic weighted average of the ratio of each stock’s market price to its net asset value. Dividend Yield is the harmonic weighted average of the ratio of each stock’s annual dividend per share to its market price. Price-to-Earnings, Price-to-Book and Dividend Yield are calculated as of 3/31/18. Turnover shows the average buying and selling activity in the portfolio in terms of how much of the index’s value changed from 01/04/2017 to 3/31/18 calculated by taking the sum of the daily purchases and sales and dividing the lesser of the absolute value of both by the average assets during the entire period, expressed as an annualized percentage. P/E, P/B, Dividend Yield, and Turnover are calculated by Syntax via FactSet. Top holdings and security classifications used in calculating allocation tables are based on ending weight as of 3/31/18.